Tag Archives: Cost effectiveness

Probiotics: are they cost effective?

Like almost any intervention in the NICU (even maternal breast milk requires pumps and equipment, and kangaroo care requires chairs) there is some cost associated with routine probiotic administration. A new publication attempts to calculate the cost-effectiveness relationship. (Craighead AF, … Continue reading

Posted in Neonatal Research | Tagged , , | Leave a comment

Palivizumab for late preterm infants, can we afford it?

It is quite clear that palivizumab reduces the incidence of RSV disease, and probably also the severity, among those who still get it nevertheless. It is just as clear that it is extremely expensive. If RSV is likely to make … Continue reading

Posted in Neonatal Research | Tagged , , | 6 Comments